Navigation Links
Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
Date:10/5/2007

COLUMBIA, Md., Oct. 5 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced today that it has entered into a multi-year license and supply agreement with Alter Farmacia, S.A. for the inclusion of Martek's arachidonic acid (ARA) oil in Alter's infant formula products. Under the terms of the agreement, Alter Farmacia will purchase Martek's ARA for all of its infant formula products that contain ARA sold in Spain and Portugal.

Headquartered in Spain, Alter Farmacia is part of the Alter Group and markets baby foods, infant formula, and cosmetics.

Naturally present in human breast milk, ARA is an essential fatty acid important to infant development and growth. When used in combination with DHA, clinical studies have demonstrated numerous benefits for infants receiving ARA supplemented formula. Martek's ARA is the only ARA currently used in U.S. infant formulas, and is present in more than 90 percent of infant formula sold in the U.S.

"This product launch is another step towards Martek's goal of further expanding our infant formula market outside of the U.S., where we are already in more than 90 percent of infant formulas sold," said Steve Dubin, CEO of Martek. "It's satisfying to know that with every new license agreement, more and more infants around the world will benefit from Martek's products."

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2006 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.

CONTACT

Cassie France-Kelly

Public Relations

(443) 542-2116

cfrancekelly@martek.com

Kyle Stults

Investor Relations

(410) 740-0081

investors@martek.com


'/>"/>
SOURCE Martek Biosciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Filtration treatment assigns more live kidney donation
2. Depressed women show signs of earlier onset of Perimenopause
3. More signs to an approaching migraine attack
4. An Indian Bride with signs of SARS
5. Recognize Heart Attack Signs
6. Parents Should Look For Signs Of Children Becoming Overweight
7. Early Warning Signs Of Heart Disease
8. Warning Signs On Powered Baby Milk
9. Genetical Screening Can Detect Early Signs Of Multiple Sclerosis
10. Diagnosis of Alzheimers years before clinical signs emerge
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... Horizon Goodwill ... a unique opportunity that helps high school girls succeed in STEM programs as ... Horizon Goodwill will host over 20 high school girls at their corporate ...
(Date:7/24/2017)... OH (PRWEB) , ... July 24, 2017 , ... The ... on the life-altering neurological condition called essential tremor (ET). The seminar will take place ... 5800 Rockside Woods Blvd., Independence, OH. The program will run from 9 a.m. to ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... media initiatives designed to promote awareness for Topricin’s revolutionary, natural, after-burn skin care ... one of the leading causes of long term skin conditions, including cancer. ...
(Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the ... announces the issuance of United States Patent Number 9,695,398 (the '398 patent) and ... The '398 and '324 patents cover methods and systems for optimizing fat ...
(Date:7/24/2017)... ... 2017 , ... Sharon Kleyne, host of the nationally syndicated The Sharon Kleyne ... Nature’s Tears® EyeMist® recently talked on the air about an alarming Post magazine article ... by Zidor Aldama described the situation in which Chinese children are under pressure to ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... Medical Products, a leader in medical product innovation and global patient ... for hospice patient care. ... Centurion Medical Products ... pain management and emotional comfort are part of a hospice,s primary ... preventing unneeded emergency department admission due to severe fecal impaction. One ...
(Date:7/12/2017)... 12, 2017  Eli Lilly and Company (NYSE: ... companies to resolve pending patent litigation in the U.S. District ... regarding the Cialis ® (tadalafil) unit dose patent. ... 2020. As part of the agreement, Cialis exclusivity is now ... "The unit dose patent for Cialis is valid ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
Breaking Medicine Technology: